That’s not what you get when you use Dr. Shoemaker’s method to find out about mold. You get very close to a sure thing. You’ll know with near certainty if you’re being made sick by mold toxins and have a protocol that has a damn good chance of making real headway in getting you better. So maybe you do have dental infections, Lyme and a couple of co-infections, heavy metal poisoning, parasites, and so on. Maybe you’re taking enough Mepron to revive the dead, have done over forty 1-hour HBOT sessions, FIR saunas until you looked like a shriveled grape, and some really far out treatments that puts you firmly in the top 5% of the most die-hard alternative medicine folks right along side with me. However, take it from someone that’s treated the gamut of chronic illness suspects with a total commitment that only someone driven by extreme, unrelenting inflammatory based borderline psychosis and anxiety can know, go after the mold first. I’ll say it again. It’s pretty easy to figure out if mold is a problem for you, and if it is, then there are very real steps you can take that will make you feel a whole lot better.
You'll never get a Job if you don't have a Good Answer to this frequently asked job interview question!
Select the right answer to determine if you are prepared for a successful job interview.
Why Do You Want This Job?
Select the right answer:
I would like to gain knowledge and experience in this line of work
This job offers long-term career development
This job is a real opportunity for me to grow and develop
I can make an impact and bring benefit to the company
This job will help me assume another level in my career
In the single-arm trial, 48% of patients (n = 62) were ≥ 65 years of age and 10% of patients (n=13) were ≥ 75 years of age [See Clinical Studies ]. The median age of the trial population was 63 years. Patients ≥ 65 years of age had a higher response rate to Beleodaq treatment than patients < 65 years of age (36% versus 16%) while no meaningful differences in response rate were observed between patients ≥ 75 years of age and those < 75 years of age. No clinically meaningful differences in serious adverse reactions were observed in patients based on age (< 65 years compared with ≥ 65 years or < 75 years of age compared with ≥ 75 years of age).